Flawed Analysis Misleads Public About Calcium and Heart Attack RiskNovember 2010
The media is at it again—reporting deceptive propaganda by the medical establishment as if it were scientific fact.
Just imagine the epidemic of osteoporosis that will occur if women stop taking their calcium supplements. That will happen if the public relies on mainstream news reporters to make their health decisions.
In a biased and horrifically flawed analysis, a group of doctors came to the conclusion that calcium supplements increase heart attack risk by 27%.1
Omitted from the media reports were critical facts such as the exclusion of people who took vitamin D, magnesium, or other nutrients typically found in bone protection formulations.
In other words, calcium-supplemented study subjects (who the mainstream claims suffered higher heart attack rates) would have been seriously deficient in vitamin D and magnesium—two essential nutrients that protect against heart attack.
The doctors who compiled this analysis also conveniently omitted major clinical trials showing that those with higher calcium intake had significantly lower cardiovascular rates.
A technical rebuttal by Steven Joyal, MD, to this flawed study appears on the next page. We need to emphasize, however, the critical need to supplement with other nutrients when taking calcium for optimal effect.
As we age, the body’s internal regulators of calcium deposition become dysfunctional. Scientists have uncovered a deficiency of vitamin K as being a factor that enables calcium to infiltrate the inner lining of arteries to cause arterial calcification. By ensuring optimal vitamin K status, calcium is directed to the bone and away from the arterial wall. Fortunately, Life Extension® members obtain vitamin K in the Super Booster multi-nutrient caps, Super K capsules, and other formulas.
Magnesium is another critical nutrient for bone and cardiovascular health. Of interest, magnesium is considered a natural calcium-channel blocker.2,3 For optimal bone and cardiovascular health, nutritional experts for the past 40 years have urged those who take calcium to also supplement with magnesium and vitamin D. Life Extension members obtain magnesium and vitamin D in Bone Restore and other bone-support formulas.
Optimal bone health and protection against atherosclerosis requires a multifactorial approach that involves far more than taking only calcium. The recently published meta-analysis, flawed as it is, offers a valuable lesson to the serious supplement user, i.e., lack of careful scientific analysis creates seriously flawed conclusions.
Rebuttal to Meta-analysis Claiming that Calcium Increases Myocardial Infarction (Heart Attack) RiskBy Steven Joyal, MD
On July 30, 2010, a meta-analysis published in the British Journal of Medicine reported that calcium supplementation was associated with a significant increase in risk for heart attack. Specifically, of the 11 trials included, defined by the authors as having “trial level data,” the authors reported a 27% increase in relative risk for heart attack in patients allocated to calcium supplementation (pooled relative risk, 1.27; 95% confidence interval 1.01–1.59, p-value=0.038).1
A careful examination of the study methodology reveals several major flaws that severely compromise the authors’ conclusions.
In addition, four of the contributing authors of this meta-analysis were involved in pharmaceutical development trials involving calcium supplementation, including Wyeth, Mission Pharmacal, Shire Pharmaceuticals, and Nycomed.
Four Major Flaws Identified in Study:
The study authors indicate that vitamin D3 supplementation reduces mortality,4 yet excluded trials that used vitamin D3 in combination with calcium supplementation vs. a placebo comparator.
In fact, vitamin D deficiency has been shown to increase cardiovascular risk.5 Careful review of the 11 studies with trial data included by the authors in the meta-analysis reveals very low levels of 25-hydroxy-vitamin D3, ranging from 18.0 to 37.2 ng/mL (optimal levels are over 50 ng/mL).
Based upon the vitamin D insufficiency observed in the trial data included in this meta-analysis, the finding of an increase in heart attack risk is not surprising.
The Boston Nurses’ Health Study found that women in the highest fifth for calcium intake from supplements and diet had an adjusted relative risk of ischemic stroke of 0.69 (95% confidence interval 0.50 to 0.95) compared with those in the lowest fifth;6 this translates to a 31% reduction in stroke in those with the highest calcium intake.
The Iowa Women’s Health Study found a one-third reduction in deaths from cardiovascular events in women whose calcium intake from supplements and diet was in the highest fourth compared with those in the lowest fourth;7
The United Kingdom study of ischemic heart disease and calcium intake reported higher calcium intake reduced mortality for ischemic heart disease.8
Calcium supplementation, as well as dietary calcium, reduces blood pressure,9 a major risk factor for heart attack and stroke.
Calcium supplementation increases the ratio of high density lipoprotein (HDL) cholesterol to low density lipoprotein (LDL) cholesterol by almost 20% in healthy postmenopausal women.10
Calcium supplementation reduces body weight and promotes reductions in blood pressure in aging women.11
Given the alarming level of vitamin D deficiency observed in the trial data included in this meta-analysis, the finding of an increase in heart attack risk is not unexpected. Furthermore, exclusion of a variety of calcium trials that show beneficial effects on cardiovascular risk (as well as blood pressure and body weight) suggests author bias.
A characteristic of normal aging involves calcification in soft tissues throughout the body such as heart and blood vessels.12-14
In contrast to the stated conclusion (i.e. calcium supplementation is associated with an increase in heart attack risk) of the current meta-analysis, scientific experiments suggest the opposite to be true. For example, in validated models of atherosclerosis, calcium-deficient diets increase the rate of tissue calcification by 170% while calcium-supplemented diets, on the other hand, reduce calcification by 62%.15
The explanation for this apparent contradiction is that in response to insufficient blood levels of calcium, the body robs our bones16 and, without adequate vitamin K, saturates the arterial wall with calcium. In the arterial wall, vitamin K regulates a protein (matrix Gla protein) that protects against arterial calcification.
The importance of vitamin K for bone and cardiovascular health was not discussed, acknowledged, or described by the authors in this meta-analysis claiming that calcium increases heart attack risk. Vitamin K is critical to ensure optimal carboxylation of matrix Gla protein (MGP) in healthy subjects. The majority of MGP in the carotid arterial lining of patients with atherosclerosis is undercarboxylated.17 Serum undercarboxylated MGP is decreased in patients at risk of cardiovascular calcification due to deposition of undercarboxylated MGP in areas of vascular calcification.18
Most Life Extension® members already obtain high doses of vitamin K in the Super Booster or Super K formulas.
Health conscious individuals should make sure they are supplementing with at least 300-500 mg of elemental magnesium each day. Some people require higher magnesium intake for optimal tissue saturation. Those with kidney impairment are not always able to safely take higher doses of magnesium.
The UK study... reported higher calcium intake reduced mortality for ischemic heart disease.
1. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010 Jul 29;341:c3691.
2. Iseri LT, French JH. Magnesium: nature’s physiologic calcium blocker. Am Heart J. 1984 Jul;108(1):188-93.
3. Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke. 2009 Apr;40(4):1169-7.
4. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007 Sep 10;167(16):1730-7.
5. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 Jan 29;117(4):503-11.
6. Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999 Sep;30(9):1772-9.
7. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol. 1999 Jan 15;149(2):151-61.
8. Knox EG. Ischaemic-heart-disease mortality and dietary intake of calcium. Lancet. 1973 Jun 30;301(7818):1465-7.
9. Griffith LE, Guyatt GH, Cook RJ, Bucher HC, Cook DJ. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated meta-analysis of randomized controlled trials. Am J Hypertens. 1999 Jan;12(1 Pt 1):84-92.
10. Reid IR, Mason B, Horne A, et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med. 2002 Apr 1;112(5):343-7.
11. Reid IR, Horne A, Mason B, Ames R, Bava U, Gamble GD. Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial. J Clin Endocrinol Metab. 2005 Jul;90(7):3824-9.
12. Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res. 2005 Apr 15;96(7):717-22.
13. Jono S, Shioi A, Ikari Y, Nishizawa Y. Vascular calcification in chronic kidney disease. J Bone Miner Metab. 2006;24(2):176-81.
14. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1423-30.
15. Hsu HH, Culley NC. Effects of dietary calcium on atherosclerosis, aortic calcification, and icterus in rabbits fed a supplemental cholesterol diet. Lipids Health Dis. 2006 Jun 23;5:16.
16. Sanders S, Debuse M. Endocrine and Reproductive Systems. 2nd ed. Elsevier Health Sciences; 2003:89-90.
17. Schurgers LJ, Teunissen KJ, Knapen MH, et al. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1629-33.
18. Cranenburg EC, Vermeer C, Koos R, et al. The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res. 2008;45(5):427-36.